Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand (vol 6, pg 1167, 2000)

Bielekova, B Goodwin, B Richert, N Cortese, I Kondo, T Afshar, G Gran, B Eaton, J Antel, J Frank, JA McFarland, HF Martin, R

B. Bielekova et al., Encephalitogenic potential of the myelin basic protein peptide (amino acids 83-99) in multiple sclerosis: Results of a phase II clinical trial with an altered peptide ligand (vol 6, pg 1167, 2000), NAT MED, 6(12), 2000, pp. 1412-1412

1

Research/Laboratory Medicine & Medical Tecnology","Medical Research General Topics

NATURE MEDICINE

10788956 → ACNP

6

12

2000

1412 - 1412

ISI

1078-8956(200012)6:12<1412:EPOTMB>2.0.ZU;2-H